Delivery Order SPE2DB22D2206-SPE2DB25FJP02
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,435.46 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials. This delivery order, issued on September 4, 2025, represents a competitive, non-set-aside award with firm fixed pricing and an ultimate completion date of September 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. Yervoy is an immunotherapy medication used in cancer treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a $25,022.41 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Yervoy 200 mg/40 mL vials. The contract represents a firm fixed-price delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply...
- The U.S. Department of Defense's Medical Supply Chain awarded a $22,957.99 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Yervoy 200 mg/40 mL vials. This competitive award, with an ultimate completion date of August 19, 2025, represents a firm fixed-price contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. Yervoy (ipilimumab) is an immunotherapy...
- The Defense Logistics Agency awarded a delivery order valued at $22,870.92 to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials on July 2, 2025, with completion targeted for July 24, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order performed at the contractor's facility in Conshohocken, Pennsylvania. Yervoy is a specialized immunotherapy pharmaceutical used in oncology treatment, reflecting the critical role AmerisourceBergen plays in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Yervoy (ipilimumab) 50 mg/10 mL vials, with a contract ceiling value of $11,435.46. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Yervoy 50 mg/10 mL vials with a ceiling value of $11,435.46. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and no set-aside designation was utilized. The contract represents a competitive award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a $49,957.75 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Yervoy 200 mg/40 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $13,499.88 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 ml vials, with a completion date of June 24, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $11,435.46 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Yervoy 50 mg/10 ml vials. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA....
- The Defense Logistics Agency awarded a $37,864.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of YERVOY (ipilimumab) 200 mg/40 mL vials. The contract, awarded on May 12, 2025, with an ultimate completion date of June 3, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...